299 related articles for article (PubMed ID: 12354711)
1. Construction of autologous human heart valves based on an acellular allograft matrix.
Cebotari S; Mertsching H; Kallenbach K; Kostin S; Repin O; Batrinac A; Kleczka C; Ciubotaru A; Haverich A
Circulation; 2002 Sep; 106(12 Suppl 1):I63-I68. PubMed ID: 12354711
[TBL] [Abstract][Full Text] [Related]
2. Flow-dependent re-endothelialization of tissue-engineered heart valves.
Lichtenberg A; Cebotari S; Tudorache I; Sturz G; Winterhalter M; Hilfiker A; Haverich A
J Heart Valve Dis; 2006 Mar; 15(2):287-93; discussion 293-4. PubMed ID: 16607913
[TBL] [Abstract][Full Text] [Related]
3. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells.
Fang NT; Xie SZ; Wang SM; Gao HY; Wu CG; Pan LF
Chin Med J (Engl); 2007 Apr; 120(8):696-702. PubMed ID: 17517187
[TBL] [Abstract][Full Text] [Related]
4. [A xenogeneic acellularized matrix for heart valve tissue engineering: in vivo study in a sheep model].
Leyh R; Wilhelmi M; Haverich A; Mertsching H
Z Kardiol; 2003 Nov; 92(11):938-46. PubMed ID: 14634763
[TBL] [Abstract][Full Text] [Related]
5. Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells.
Sodian R; Lueders C; Kraemer L; Kuebler W; Shakibaei M; Reichart B; Daebritz S; Hetzer R
Ann Thorac Surg; 2006 Jun; 81(6):2207-16. PubMed ID: 16731156
[TBL] [Abstract][Full Text] [Related]
6. Preclinical development of tissue-engineered vein valves and venous substitutes using re-endothelialised human vein matrix.
Teebken OE; Puschmann C; Breitenbach I; Rohde B; Burgwitz K; Haverich A
Eur J Vasc Endovasc Surg; 2009 Jan; 37(1):92-102. PubMed ID: 19008126
[TBL] [Abstract][Full Text] [Related]
7. Clinical application of tissue engineered human heart valves using autologous progenitor cells.
Cebotari S; Lichtenberg A; Tudorache I; Hilfiker A; Mertsching H; Leyh R; Breymann T; Kallenbach K; Maniuc L; Batrinac A; Repin O; Maliga O; Ciubotaru A; Haverich A
Circulation; 2006 Jul; 114(1 Suppl):I132-7. PubMed ID: 16820562
[TBL] [Abstract][Full Text] [Related]
8. [Preparation of heart valve scaffold and cell seeding].
Long L; Wu C; Pan L; Qi X; Hong T
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Aug; 21(4):610-3. PubMed ID: 15357443
[TBL] [Abstract][Full Text] [Related]
9. [Preparation of acellularized porcine heart valve and seeding of bovine aortic endothelial cells].
Ye FL; Xu ZY; Zhang BR
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2003 Nov; 17(6):493-5. PubMed ID: 14663951
[TBL] [Abstract][Full Text] [Related]
10. Prototype anionic detergent technique used to decellularize allograft valve conduits evaluated in the right ventricular outflow tract in sheep.
Hilbert SL; Yanagida R; Souza J; Wolfinbarger L; Jones AL; Krueger P; Stearns G; Bert A; Hopkins RA
J Heart Valve Dis; 2004 Sep; 13(5):831-40. PubMed ID: 15473487
[TBL] [Abstract][Full Text] [Related]
11. In vivo remodeling and structural characterization of fibrin-based tissue-engineered heart valves in the adult sheep model.
Flanagan TC; Sachweh JS; Frese J; Schnöring H; Gronloh N; Koch S; Tolba RH; Schmitz-Rode T; Jockenhoevel S
Tissue Eng Part A; 2009 Oct; 15(10):2965-76. PubMed ID: 19320544
[TBL] [Abstract][Full Text] [Related]
12. The decellularized porcine heart valve matrix in tissue engineering: platelet adhesion and activation.
Kasimir MT; Weigel G; Sharma J; Rieder E; Seebacher G; Wolner E; Simon P
Thromb Haemost; 2005 Sep; 94(3):562-7. PubMed ID: 16268473
[TBL] [Abstract][Full Text] [Related]
13. Tissue engineering of heart valves: biomechanical and morphological properties of decellularized heart valves.
Tudorache I; Cebotari S; Sturz G; Kirsch L; Hurschler C; Hilfiker A; Haverich A; Lichtenberg A
J Heart Valve Dis; 2007 Sep; 16(5):567-73; discussion 574. PubMed ID: 17944130
[TBL] [Abstract][Full Text] [Related]
14. Living autologous heart valves engineered from human prenatally harvested progenitors.
Schmidt D; Mol A; Breymann C; Achermann J; Odermatt B; Gössi M; Neuenschwander S; Prêtre R; Genoni M; Zund G; Hoerstrup SP
Circulation; 2006 Jul; 114(1 Suppl):I125-31. PubMed ID: 16820561
[TBL] [Abstract][Full Text] [Related]
15. In vivo autologous recellularization of a tissue-engineered heart valve: are bone marrow mesenchymal stem cells the best candidates?
Vincentelli A; Wautot F; Juthier F; Fouquet O; Corseaux D; Marechaux S; Le Tourneau T; Fabre O; Susen S; Van Belle E; Mouquet F; Decoene C; Prat A; Jude B
J Thorac Cardiovasc Surg; 2007 Aug; 134(2):424-32. PubMed ID: 17662783
[TBL] [Abstract][Full Text] [Related]
16. The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning.
Flanagan TC; Cornelissen C; Koch S; Tschoeke B; Sachweh JS; Schmitz-Rode T; Jockenhoevel S
Biomaterials; 2007 Aug; 28(23):3388-97. PubMed ID: 17467792
[TBL] [Abstract][Full Text] [Related]
17. Evolution of cell phenotype and extracellular matrix in tissue-engineered heart valves during in-vitro maturation and in-vivo remodeling.
Rabkin E; Hoerstrup SP; Aikawa M; Mayer JE; Schoen FJ
J Heart Valve Dis; 2002 May; 11(3):308-14; discussion 314. PubMed ID: 12056720
[TBL] [Abstract][Full Text] [Related]
18. A tissue engineered heart valve implanted in a juvenile sheep model.
Dohmen PM; Ozaki S; Nitsch R; Yperman J; Flameng W; Konertz W
Med Sci Monit; 2003 Apr; 9(4):BR97-BR104. PubMed ID: 12709659
[TBL] [Abstract][Full Text] [Related]
19. Tissue engineering of cardiac valve prostheses I: development and histological characterization of an acellular porcine scaffold.
Booth C; Korossis SA; Wilcox HE; Watterson KG; Kearney JN; Fisher J; Ingham E
J Heart Valve Dis; 2002 Jul; 11(4):457-62. PubMed ID: 12150290
[TBL] [Abstract][Full Text] [Related]
20. From stem cells to viable autologous semilunar heart valve.
Sutherland FW; Perry TE; Yu Y; Sherwood MC; Rabkin E; Masuda Y; Garcia GA; McLellan DL; Engelmayr GC; Sacks MS; Schoen FJ; Mayer JE
Circulation; 2005 May; 111(21):2783-91. PubMed ID: 15927990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
